- Home
- THTX vs IAF Comparison
THTX vs IAF Comparison
Compare THTX & IAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THTX
- IAF
- Stock Information
- Founded
- THTX 1993
- IAF 1985
- Country
- THTX Canada
- IAF United States
- Employees
- THTX N/A
- IAF N/A
- Industry
- THTX Biotechnology: Pharmaceutical Preparations
- IAF Finance/Investors Services
- Sector
- THTX Health Care
- IAF Finance
- Exchange
- THTX Nasdaq
- IAF Nasdaq
- Market Cap
- THTX 119.1M
- IAF 123.8M
- IPO Year
- THTX N/A
- IAF N/A
- Fundamental
- Price
- THTX $3.16
- IAF $4.43
- Analyst Decision
- THTX Hold
- IAF
- Analyst Count
- THTX 1
- IAF 0
- Target Price
- THTX N/A
- IAF N/A
- AVG Volume (30 Days)
- THTX 1.0M
- IAF 90.4K
- Earning Date
- THTX 07-09-2025
- IAF 01-01-0001
- Dividend Yield
- THTX N/A
- IAF 11.44%
- EPS Growth
- THTX N/A
- IAF N/A
- EPS
- THTX N/A
- IAF N/A
- Revenue
- THTX $84,378,000.00
- IAF N/A
- Revenue This Year
- THTX N/A
- IAF N/A
- Revenue Next Year
- THTX $15.13
- IAF N/A
- P/E Ratio
- THTX N/A
- IAF N/A
- Revenue Growth
- THTX 2.19
- IAF N/A
- 52 Week Low
- THTX $1.12
- IAF $3.60
- 52 Week High
- THTX $3.20
- IAF $4.59
- Technical
- Relative Strength Index (RSI)
- THTX 73.38
- IAF 47.97
- Support Level
- THTX $3.14
- IAF $4.41
- Resistance Level
- THTX $3.20
- IAF $4.56
- Average True Range (ATR)
- THTX 0.06
- IAF 0.05
- MACD
- THTX 0.06
- IAF -0.01
- Stochastic Oscillator
- THTX 94.93
- IAF 10.00
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.
About IAF abrdn Australia Equity Fund Inc.
Aberdeen Australia Equity Fund Inc is a non-diversified closed-end investment management company. With a core focus on long-term capital appreciation, it invests predominantly in equity securities listed on the Australian Stock Exchange. Its secondary objective is current income, which it expects to derive from dividends and interest on Australian corporate and governmental securities. Its investment portfolio comprises diversified sectors that include Financials, Health Care, Materials, Information Technology, Real Estate, and other sectors.